Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically important. In this study, we propose a dual-model radiomic analysis with multivariate Cox proportional hazards regression models to investigate promising risk factors associated with MCI conversion to AD. T1 structural magnetic resonance imaging (MRI) and 18F-Fluorodeoxyglucose (FDG) positron emission tomography (PET) data, from the AD Neuroimaging Initiative database, were collected from 131 patients with MCI who converted to AD within 3 years and 132 patients with MCI without conversion within 3 years. These subjects were randomly partition into 70% training dataset and 30% test dataset with multiple times. We fused MRI and PET images by wa...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) are associated with widespread changes ...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically ...
Objective: This study aimed to build and validate a radiomics-integrated model with whole-brain magn...
AimThe value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cognitive...
Aim: The value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cogniti...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Selecting a set of relevant markers to predict conversion from mild cognitive impairment (MCI) to Al...
Background: Noninvasive identification of amyloid-β (Aβ) is important for better clinical management...
We present a method to discover interesting brain regions in [18F] fluorodeoxyglucose positron emiss...
Hippocampal morphological change is one of the main hallmarks of Alzheimer's disease (AD). However, ...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) are associated with widespread changes ...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer's disease (AD) is clinically ...
Predicting progression of mild cognitive impairment (MCI) to Alzheimer’s disease (AD) is clinically ...
Objective: This study aimed to build and validate a radiomics-integrated model with whole-brain magn...
AimThe value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cognitive...
Aim: The value of 18F-fluorodeoxyglucose (FDG) PET for the prognosis of conversion from mild cogniti...
Mild cognitive impairment is a preclinical stage of Alzheimer's disease (AD). For effective treatmen...
For patients with mild cognitive impairment (MCI), the likelihood of progression to probable Alzheim...
Selecting a set of relevant markers to predict conversion from mild cognitive impairment (MCI) to Al...
Background: Noninvasive identification of amyloid-β (Aβ) is important for better clinical management...
We present a method to discover interesting brain regions in [18F] fluorodeoxyglucose positron emiss...
Hippocampal morphological change is one of the main hallmarks of Alzheimer's disease (AD). However, ...
Objectives: Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most c...
Alzheimer’s Disease (AD) and mild cognitive impairment (MCI) are associated with widespread changes ...
Prediction of conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) is of majo...